The START Center for Cancer Research

📍 San Antonio, United States👥 52 employees💰 Last funded 2024
Biotechnology Research🌐 startresearch.com
Website LinkedIn
Deeply rooted in community oncology centers globally, the START Center for Cancer Research provides patients with access to specialized Phase 1 clinical trials for novel anti-cancer agents. With research sites in the United States and in Spain, Portugal, and Ireland, START’s clinical trial sites have conducted more than 1,300 early phase clinical trials, including for 43 therapies that have gained FDA/EMA approval. Founded in Texas in 2007, START today boasts 25 Principal Investigators (PIs) across its worldwide clinical trial sites. With over 100,000+ square feet of world-class research facilities, START offers patients comprehensive treatment plans that include multi-specialty services, genetic profiling of tumors, targeted therapies, state-of-the-art treatment technology, and advanced access to clinical research options. START is committed to accelerating passage from trials to treatments, and to delivering hope to patients, families, and physicians around the world.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in The START Center for Cancer Research?
The START Center for Cancer Research has 1 investors on record on gritt.io.
When did The START Center for Cancer Research last raise funding?
The most recent investment in The START Center for Cancer Research recorded on gritt.io was in 2024.
What industry is The START Center for Cancer Research in?
The START Center for Cancer Research operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is The START Center for Cancer Research based?
The START Center for Cancer Research is headquartered in San Antonio, United States.